PFE Pfizer Inc.

bullish 0/2 shifts correct ↓ $26.14 -0.07 (-0.3%)
Mkt Cap $147B P/E 19.7 fwd 9.1 52wk $23.06 - $28.75 6d ago
Factor divergence: DIVERGENCE: insider_activity bullish vs analyst_revisions bearish
Est. revisions: +0.3% (6 up, 8 down in 30d)
Factor Model (net +0.1)

Factor Model

net +0.1 2.0 / 10
Est. Revisions
+0.0
Insider Activity
+0.5
Momentum
-0.0
Analyst Rev.
-0.3
Narrative Gap
+0.0

Pfizer CEO Leverages AI to Boost Decisions

Watch: Monitor Pfizer's next strategic moves driven by AI insights to assess impact on growth and innovation pipelines.

Pfizer CEO Albert Bourla uses AI to supplement key business decisions, mirroring 64% of CEOs globally adopting AI for strategic input, according to IBM Institute for Business. This marks a shift in decision-making processes, potentially enhancing Pfizer's adaptability and strategic insight. The trend is gaining momentum across the CEO community, signaling wider AI integration.

AI adoption at executive level enhances Pfizer's decision-making efficiency and strategic foresight, possibly improving competitive positioning and portfolio value in a highly dynamic pharma market.

Evidence

6d ago Pfizer's CEO uses AI to make his biggest calls — and 64% of CEOs agree, quietly shifting your portfolio yahoo-finance
10d ago The SoFi CEO Just Bought 70,000 Shares With His Own Money. Here Are Four More Under $30 Worth a Closer Look yahoo-finance
15d ago Wolfe Research Says COVID Uncertainty Continues to Weigh on Pfizer (PFE) Outlook yahoo-finance
16d ago Michael Burry’s Latest Buys Include a 6.66% Yielding Pharma Giant and an Oil Stock Up 46% This Year. Here Is Why yahoo-finance
17d ago Jim Cramer on Uber: “There Aren’t Many as Good” yahoo-finance
19d ago Pfizer's Net Income Drops in Q1. Is Its Dividend Still Safe? yahoo-finance
23d ago Pfizer’s newer medicines carry more weight in Q1 yahoo-finance
24d ago Hantavirus stock predictions ? reddit-stocks
7 older signals
24d ago Cancer Treatments Propel Pfizer Sales Growth as Covid Revenue Dwindles
26d ago Morning Bid: Gulf singe, AI binge
27d ago Guggenheim Reaffirms Buy on Pfizer (PFE) Ahead of Pipeline Catalysts
27d ago Factbox-Global drugmakers rush to boost US presence as tariff threat looms
27d ago How To Earn $500 A Month From Pfizer Stock Ahead Of Q1 Earnings
32d ago Citigroup main PFE: Neutral → Neutral
36d ago Wall Street Says Buy Merck Over Pfizer. The Numbers Tell a More Complicated Story.
Fundamentals & Data ▾
Pfizer Inc. Healthcare · Drug Manufacturers - General
Mkt Cap
$147B
P/E
19.7 fwd 9.1
Beta
0.30
Div Yield
665.00%
52w Range
$23.06 - $28.75
Short Interest
140.3M 2.46%
Days to Cover
4.0 +6%
Technicals mixed
vs 20d MA
+1.3%
from 52w Hi
-7.5%
Vol (20d)
13%
1w return
+2.1%
1m return
-2.2%
Vol ratio
0.8x
Insiders
mixed 1B / 1S
Analysts
bullish 1 up / 0 down
EPS Estimate
$0.68 +0.3% 30d 6up / 8dn
Est. Dispersion
22% 18 analysts
Analyst Target
$29 $24 - $36
Options P/C
0.64
Fund Convergence
strong D.E. Shaw, Citadel, Two Sigma
Financials
Revenue
$14.4B +5% YoY
FCF
$2.2B
Gross Margin
75%
Op Margin
29%
Momentum: decelerating
Top Holders
D.E. Shaw $1.3B
Citadel $855M
Point72 $153M
Two Sigma
Track Record (0/2 correct) ▾

Direction History

0/2 correct at 5 days
2026-05-14 bearish +0.8% ✗
2026-05-05 bullish -0.6% ✗
Full track record across all stocks →
15 signals · latest 6d ago

Keep reading the market

Direction shifts, insider clusters, filing red flags, and earnings call changes stay published on the site.

All stocks → Track record → How it works →